Top 10 Books about Stock Investing to read in 2018. Read more.

EBIO - Eleven Biotherapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

EBIO - Eleven Biotherapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Fri 25'th May 2018

PERIOD 2018-02-26 - 2018-05-25
CHANGE 0.00%
PRICE $3.29





Request Prediction

Eleven Biotherapeutics Stock Analysis

Technical stock analysis for Fri 25'th May 2018

Buy candidate since 2018-04-16 Gain 108.23%

No changes to the price of Eleven Biotherapeutics in the last trading day. The price has been going up and down for this period, and there has been a 17.08% gain for the last 2 weeks.

Shorts 0.78% ( 2018-04-30 )
Cash 27.1 mill
Loans n/a
Beta 2.85
ROA -32.40


Eleven Biotherapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 227.91% during the next 3 months and, with 90% probability hold a price between $8.79 and $13.10 at the end of this period.

Click here for today's Top 5 Trending Companies


Eleven Biotherapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $3.29 and $2.52. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday May 24, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

A sell signal from a double top formation was found on Thursday May 24, 2018 and based on theory for this formation the price should fall by -0.84% to $2.45 within 15 trading days since signal was issued (Friday June 15, 2018).

Relative Strength Index (RSI)

RSI14 is 60 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Eleven Biotherapeutics finds support from accumulated volume at $3.22.

Support: $3.22 Price: $3.29


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.00 between high and low, or 0.00%. For the last week the stock has had a daily average volatility of 0.00%.

Our recommended stoploss: $3.16 (-3.80%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Trade EBIO CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features